drugset / Trial / NCT05324839
A Study of Botulinum Toxin Type A Treatment of Wrinkles in Asian
RandomizedParallel-groupDouble-blindTreatment
Summary
OBJECTIVES: The aim of this randomized, parallel-group, double-blinded controlled multicenter clinical trial is to determine the proper dosage of botulinum toxin type A in Asian, and provide evidence-based proof. METHODS: 250 patients were included in this study, first, trained observers assessed their wrinkle severity according to the 5-grade Wrinkle Severity Rating Scale before injecting botulinum toxin type A, then we injected different dosages to patients with the different pre-injection scores. All patients were followed up for up to one year. Logistic regression was built, the chi-square test was performed, and R square and p-value are used for evaluation.
Timeline
- Start
- 2014-02-01
- Primary completion
- 2014-03-01
- Completion
- 2017-03-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 1 iu | — |
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 2 iu | — |
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 3 iu | — |
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 5 iu | — |
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 6 iu | — |
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 10 iu | — |
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 15 iu | — |